The expression of IL-17 increases in the premalignant stage of CRC and directly correlates with dysplasia in the colonic adenoma-to-carcinoma sequence, making IL-17 a potential biomarker for colon cancer diagnosis and severity [8]. Here, IL17A is linked to dysplasia.